Data Foundry

Medical device recalls 2022

IMMULITE 2000 Systems 3gAllergy Specific IgE Universal Kit Tests — Class II medical device recall Z-0716-2023

Ongoing recall by Siemens Healthcare Diagnostics, Inc., reported 2022-12-21, distributed nationwide. Potential for falsely elevated specific IgE mold allergen reactivity with quality control material and patient

Recall numberZ-0716-2023
Product typeMedical device
ClassificationClass II
StatusOngoing
Voluntary or mandatedVoluntary
Recalling firmSiemens Healthcare Diagnostics, Inc., East Walpole, MA, United States
Recall initiated2022-11-04
Classified2022-12-15
Reported by FDA2022-12-21
DistributedNationwide (US)
Countries outside the USAR, AT, AU, BE, BR, CH, CL, CO, CZ, DE, DK, EC, EE, EG, ES, FR, GT, HR, HU, ID, IL, IT, JP, LT, LV, MX, NL, NO, PA, PH, PK, PL, PT, PY, RO, RS, SE, SI, SK, TR, TW, UA, UY
Quantity1,000 kits
Reason classesundeclared allergen, microbial contamination
Pathogensmold
UPC / GTIN / UDI-DI00630414982939
Lot numbersD830, D831, D832, D833

Product

IMMULITE 2000 Systems 3gAllergy Specific IgE Universal Kit Tests (600T)- US. Siemens Material Number (SMN): 10708840 For in vitro diagnostic use with the IMMULITE 2000 Systems Analyzers for the quantitative measurement of allergen-specific IgE in human serum, as an aid in the clinical diagnosis of IgE mediated allergic disorders.

Reason for recall

Potential for falsely elevated specific IgE mold allergen reactivity with quality control material and patient samples, may result in false reactive result

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/Z-0716-2023. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.